Object reference not set to an instance of an object. Stock market Updates | Concord Biotech Ltd. | R Wadiwala Securities Pvt Ltd

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1391.80-50.5 (-3.5 %)
PREV CLOSE (Rs.) 1442.30
OPEN PRICE (Rs.) 1397.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 153778
TODAY'S LOW / HIGH (Rs.)1365.10 1428.00
52 WK LOW / HIGH (Rs.)900 1711.95
NSE1395.80-44.95 (-3.12 %)
PREV CLOSE( Rs. ) 1440.75
OPEN PRICE (Rs.) 1387.50
BID PRICE (QTY) 1395.80 (9209)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4968921
TODAY'S LOW / HIGH(Rs.) 1355.00 1428.00
52 WK LOW / HIGH (Rs.)900.05 1725

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
2137.64
Dividend Yield(%)
0.02
TTM EPS (Rs.)
29.13
P/E Ratio
47.78
Book Value (Rs.)
145.80
Face Value (Rs.)
1
MCap (Rs. in Mn)
145604.83
Price/Earning (TTM)
40.64
Price/Sales (TTM)
14.32
Price/Book (MRQ)
9.55
PAT Margin (%)
27.91
ROCE (%)
26.48
company info
Incorporation Year : 1984

Management Info :

Sudhir Vaid - Chairman Sudhir Vaid - Managing Director

Registered Office :

Address : 1482-86 ,Trasad Road,Dholka,
Ahmedabad,
Gujarat-382225

Phone : 079-68138700

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
News
21May Concord Biotech informs about earning
Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015, as amended..
17May Saudi Food and Drug Authority complete
Saudi Food and Drug Authority has successfully completed inspection of C..
15Apr Reply To Clarification Sought On Volu
We hereby submit that the company has disclosed all the material informa..
Financials
QTR Mar 24 ANNUAL 24
Net Profit972.153047.31
Gross Profit 1309.19 4091.93
Operating Profit 1451 4653.37
Net Sales 3189.69 10169.39
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Divi's Lab (BSE)
Rwadiwala-peer-arrow  4390.85 (3.22%)
M.Cap (Rs. in Cr)116563.27
SMS Lifesciences (BSE)
Rwadiwala-peer-arrow  821.15 (20.00%)
M.Cap (Rs. in Cr)248.26
Glaxosmithkline Phar (BSE)
Rwadiwala-peer-arrow  2484.70 (5.40%)
M.Cap (Rs. in Cr)42092.32
Dr. Reddy's Lab (BSE)
Rwadiwala-peer-arrow  5955.65 (1.21%)
M.Cap (Rs. in Cr)99351.12
Shareholding Pattern
MUTUAL FUNDS/UTI
5.15%
PROMOTERS
44.08%
NON-INSTITUTION
41.03%
FI/BANKS/INSURANCE
2.88%
GOVERNMENT
0%
FII
0%
Mf Holdings